Gene Therapy Market 2017 Global Analysis, Opportunities And Forecast To 2021
Jan 17, 2017
Gene Therapy -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021
Pune, India - January 17, 2017 /MarketersMedia/ —
Gene Therapy Industry
Description
Wiseguyreports.Com Adds “Gene Therapy -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database
This report studies Gene Therapy in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/870310-global-gene-therapy-market-professional-survey-report-2017
By types, the market can be split into
In Vivo
Ex Viv
By Application, the market can be split into
Mechanobiology Universities
Research Institutions
Other
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Leave a Query @ https://www.wiseguyreports.com/enquiry/870310-global-gene-therapy-market-professional-survey-report-2017
Table of Contents
Global Gene Therapy Market Professional Survey Report 2017
1 Industry Overview of Gene Therapy
1.1 Definition and Specifications of Gene Therapy
1.1.1 Definition of Gene Therapy
1.1.2 Specifications of Gene Therapy
1.2 Classification of Gene Therapy
1.2.1 In Vivo
1.2.2 Ex Viv
1.3 Applications of Gene Therapy
1.3.1 Mechanobiology Universities
1.3.2 Research Institutions
1.3.3 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
...
8 Major Manufacturers Analysis of Gene Therapy
8.1 Bluebird Bio
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 In Vivo
8.1.2.2 Ex Viv
8.1.3 Bluebird Bio 2015 Gene Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Bluebird Bio 2015 Gene Therapy Business Region Distribution Analysis
8.2 Sangamo
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 In Vivo
8.2.2.2 Ex Viv
8.2.3 Sangamo 2015 Gene Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Sangamo 2015 Gene Therapy Business Region Distribution Analysis
8.3 Spark Therapeutics
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 In Vivo
8.3.2.2 Ex Viv
8.3.3 Spark Therapeutics 2015 Gene Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Spark Therapeutics 2015 Gene Therapy Business Region Distribution Analysis
8.4 Dimension Therapeutics
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 In Vivo
8.4.2.2 Ex Viv
8.4.3 Dimension Therapeutics 2015 Gene Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Dimension Therapeutics 2015 Gene Therapy Business Region Distribution Analysis
8.5 Avalanche Bio
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 In Vivo
8.5.2.2 Ex Viv
8.5.3 Avalanche Bio 2015 Gene Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Avalanche Bio 2015 Gene Therapy Business Region Distribution Analysis
8.6 Celladon
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 In Vivo
8.6.2.2 Ex Viv
8.6.3 Celladon 2015 Gene Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Celladon 2015 Gene Therapy Business Region Distribution Analysis
8.7 Vical Inc.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 In Vivo
8.7.2.2 Ex Viv
8.7.3 Vical Inc. 2015 Gene Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Vical Inc. 2015 Gene Therapy Business Region Distribution Analysis
8.8 Advantagene
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 In Vivo
8.8.2.2 Ex Viv
8.8.3 Advantagene 2015 Gene Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Advantagene 2015 Gene Therapy Business Region Distribution Analysis
Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=870310
Continued...
Contact Us: [email protected] Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)
For more information, please visit https://www.wiseguyreports.com/sample-request/870310-global-gene-therapy-market-professional-survey-report-2017
Contact Info:
Name: NORAH TRENT
Email: [email protected]
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Pune 411028 , Maharashtra, India
Phone: +1-646-845-9349 / +44 208 133 9349
Release ID: 162113
More News
2 Students Are Killed in School Shooting in the Philippines
The suspect, a 16-year-old student, also died, officials said. It was the third high-profile school shooting in the Philippines in recent months.
Rejecting Trump, South Korean Leader Says He Will Not Send Troops to Iran
President Lee Jae Myung’s comments followed President Trump’s repeated demand for “a little hand” from South Korea, a decades-old American ally.
China Stockpiled Oil, and Now It Could Dominate the Energy Landscape
The war with Iran revealed just how much influence the world’s biggest oil importer has over prices and other countries’ supplies of jet fuel, gasoline and diesel.
Singapore minister Chan Chun Sing’s Mandarin diplomacy strikes China chord
Singapore Defence Minister Chan Chun Sing’s use of Mandarin and Chinese philosophy in his speech at a major security forum in Beijing has won him praise on Chinese social media, while shedding light on how cultural familiarity and language can be diplomatic tools for the city state. Videos of Chan at the Beijing Xiangshan Forum quoting ancient philosopher Mencius, or Mengzi in Mandarin, have gone viral on platforms such as Weixin and Baidu, with users hailing his command of the language and...
Thailand makes weight-loss pens prescription-only to counter glut of illegal medicines
Thailand has moved to make weight-loss pens prescription-only, as a glut of the GLP-1 medicines – which mimic the hormones released once someone is full – floods the black market and influencers swarm TikTok to extol the quick wins of the simple injections. The Southeast Asian nation, which is never far behind wellness or aesthetic trends and has a notorious black market in counterfeit drugs, has seen the uptake of GLP-1 medicines skyrocket, doctors say, including the market-leading Ozempic...
Why Singapore’s big-box gyms are losing to niche fitness studios
Property agent Raymond Heng had suspected True Fitness was struggling, but he did not expect the gym he had visited for more than a decade to disappear overnight. The closure was not entirely surprising given the region’s fiercely competitive fitness industry, but its abruptness left Heng, 47, in disbelief after paying S$8,800 (US$6,900) for a lifetime membership in 2013. “I guessed that they might not have been doing that well since branches have been closing over the years, but I did not...
Why the ICC is cracking down on ‘fake news’ as Duterte trial looms
As Rodrigo Duterte’s crimes-against-humanity trial looms, an international tribunal faces the challenge of managing a sprawling prosecution case around the health of an 81-year-old former president of the Philippines, on top of shielding the proceedings from a highly charged media environment. Those pressures came into focus at an International Criminal Court (ICC) status conference on Wednesday, when Presiding Judge Joanna Korner urged prosecutors to trim their witness list and evidence ahead...
Top Chinese AI models make 10% of OpenAI, Anthropic revenue despite high valuations: report
Chinese artificial intelligence models from seven major developers combined generate only about 10 per cent of the revenue reported for OpenAI and Anthropic, even as investor enthusiasm remains intense, according to US-based research firm Rhodium Group. The Chinese AI models earned an estimated US$10.7 billion in annual recurring revenue (ARR) from March to August, a fraction of the more than US$100 billion combined for OpenAI and Anthropic, according to the Rhodium report published on...
Japan Raises Interest Rates to 31-Year High Under U.S. Pressure
The Bank of Japan’s widely expected move followed an unusual campaign by Treasury Secretary Scott Bessent for higher rates.
Convicted of Theft, an Ex-Prime Minister Is Set to Swap Prison for Mansion
The former prime minister of Malaysia, Najib Razak, was convicted in the multibillion-dollar 1MDB scandal. He’ll serve out his time at a luxury home.
South Korea’s president rejects US request for Iran war support
South Korean President Lee Jae Myung has drawn a clear line against any US request for Seoul to join the war against Iran, explicitly ruling out the dispatch of troops or military assets that could involve his country in the conflict. The stance comes amid mounting public opposition to any military deployment and growing pressure from Washington for Seoul to contribute to efforts to secure freedom of navigation through the Strait of Hormuz. Lee’s government faces the difficult task of balancing...
Pride or practicality? Indonesia receives first aircraft carrier amid fears of upkeep cost
Indonesia welcomed its first aircraft carrier on Friday, a former Italian warship that the government says will strengthen the archipelago nation’s maritime security and disaster response capabilities. The 41-year-old former ITS Giuseppe Garibaldi, with capacity for short take-off and vertical landing aircraft and helicopters, was welcomed with a military ceremony upon its arrival at a naval base in North Jakarta’s Tanjung Priok seaport. Rome in March agreed to give the carrier, which was...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.